IMA
ImageneBio, Inc.
4.60$
+0.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | 100.0% | – | 100.0% | – | – | – | – | – | – | |
| 20.4% | 46.3% | – | – | 194.8% | – | 464.4% | – | – | – | – | – | – | |
| 79.6% | 53.7% | – | – | -194.8% | – | 100.0% | – | – | – | – | – | – | |
| 100.0% | 2,119.7% | – | – | 194.8% | – | 505.0% | – | – | – | – | – | – | |
| 509.2% | 1,258.4% | – | – | 136.5% | – | 344.4% | – | – | – | – | – | – | |
| 1,725.4% | 3,378.1% | – | – | 159.7% | – | 849.4% | – | – | – | – | – | – | |
| -1,645.8% | -3,324.4% | – | – | -354.5% | – | -749.4% | – | – | – | – | – | – | |
| – | 196.7% | – | – | – | – | – | – | – | – | – | – | – | |
| -1,463.5% | -2,981.9% | – | – | -292.1% | – | -759.6% | – | – | – | – | – | – | |
| – | -24.6% | – | – | 0.3% | – | 3.5% | – | – | – | – | – | – | |
| -1,463.5% | -2,957.4% | – | – | -292.4% | – | -759.6% | – | – | – | – | – | – | |
| -1,443.1% | -2,739.0% | – | – | -328.7% | – | -739.4% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.